Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease

Objective: to estimate the informative value and reproducibility of ultrasound study (USS) in interstitial lung disease (ILD) in patients with scleroderma systematica (SDS) and to compare ultrasound lung comet (ULC) scores with the data of multislice spiral computed tomography (MSCT) of the lung and...

Full description

Bibliographic Details
Main Authors:	Olga Borisovna Ovsyannikova, L P Ananyeva, Yu O Korsakova, O A Koneva, A V Volkov, S I Glukhova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2013-06-01
Series:	Научно-практическая ревматология
Subjects:	scleroderma systematica interstitial lung disease ultrasound study ultrasound comet scoring
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1318

Similar Items

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

Bone mineral density in patients with scleroderma systematica
by: R Т Alekperov, et al.
Published: (2016-05-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS
by: A E Karateev, et al.
Published: (2012-02-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

Pulmonary fibrosis as the first manifestation of scleroderma systematica overlap syndrome
by: N A Morova, et al.
Published: (2016-05-01)

Diagnostic value of the determination of angiogenic factors and cytokine composition parameters in the serum and urine of patients with scleroderma systematica
by: A P Rebrov, et al.
Published: (2014-05-01)

Brachial artery responsiveness in patients with systemic lupus erythematosus and scleroderma systematica
by: Aleksey Alekseevich Vinogradov, et al.
Published: (2010-03-01)

Microcirculatory disorders in scleroderma systematica: an association with vascular wall stiffness
by: Ulyana Yuryevna Ruzhentsova
Published: (2013-06-01)

Adhesion molecules in scleroderma systematica
by: R Т Alekperov, et al.
Published: (2003-05-01)

Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux
by: A V Sosnovskaya, et al.
Published: (2015-03-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

The Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
by: Shahrzad M Lari, et al.
Published: (2014-05-01)

The Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
by: Shahrzad M Lari, et al.
Published: (2014-05-01)

Performance of semi-quantitative lung ultrasound in the assessment of disease severity in interstitial lung disease
by: Ishan Kumar, et al.
Published: (2021-01-01)

Risk assessment in interstitial lung disease: the incremental prognostic value of cardiopulmonary ultrasound
by: Wei-wei Zhu, et al.
Published: (2021-07-01)

Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
by: A V Volkov, et al.
Published: (2014-05-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

B-lines: Transthoracic chest ultrasound signs useful in assessment of interstitial lung diseases
by: Ali A Hasan, et al.
Published: (2014-01-01)

A case of sine scleroderma with parenchymal lung disease
by: Mansoor Karimifar, et al.
Published: (2014-01-01)

Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases
by: E V Nikolaeva, et al.
Published: (2015-05-01)

Thoracic ultrasonography in the evaluation of lung parenchyma in interstitial lung diseases
by: Coskun Dogan, et al.
Published: (2020-01-01)

A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis
by: Hai Qin Xie, et al.
Published: (2019-04-01)

Lung ultrasound: Present and future
by: Ashish Saraogi
Published: (2015-01-01)

Correlation between Transthoracic Lung Ultrasound Score and HRCT Features in Patients with Interstitial Lung Diseases
by: Milena Adina Man, et al.
Published: (2019-08-01)

Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease
by: Silvia Mongodi, et al.
Published: (2020-05-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

Treatment of Systemic Sclerosis Associated Interstitial Lung Disease
by: Iris Yan Ki Tang, et al.
Published: (2020-12-01)

Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
by: Ludivine Renaud, et al.
Published: (2020-03-01)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
by: Mehdi Mirsaeidi, et al.
Published: (2019-10-01)

Ultrasound evaluation of diaphragmatic mobility in patients with idiopathic lung fibrosis: a pilot study
by: Andrea Boccatonda, et al.
Published: (2018-12-01)

Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
by: Angela Ceribelli, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_bfep7if2bbsjree4sfont4em9c